BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29661604)

  • 1. Cardiovascular risk assessment in prediabetic patients in a hypertensive population: The role of cystatin C.
    Garcia-Carretero R; Vigil-Medina L; Mora-Jimenez I; Soguero-Ruiz C; Goya-Esteban R; Ramos-Lopez J; Barquero-Perez O
    Diabetes Metab Syndr; 2018 Sep; 12(5):625-629. PubMed ID: 29661604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
    Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
    JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C as a predictor of cardiovascular outcomes in a hypertensive population.
    Garcia-Carretero R; Vigil-Medina L; Barquero-Perez O; Goya-Esteban R; Mora-Jimenez I; Soguero-Ruiz C; Ramos-Lopez J
    J Hum Hypertens; 2017 Dec; 31(12):801-807. PubMed ID: 28934189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes.
    Sasso FC; Pafundi PC; Caturano A; Galiero R; Vetrano E; Nevola R; Petta S; Fracanzani AL; Coppola C; Di Marco V; Solano A; Lombardi R; Giordano M; Craxi A; Perrella A; Sardu C; Marfella R; Salvatore T; Adinolfi LE; Rinaldi L
    Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2345-2353. PubMed ID: 34053830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cystatin C for risk stratification of prediabetes and diabetes populations.
    Xiong K; Zhang S; Zhong P; Zhu Z; Chen Y; Huang W; Wang W
    Diabetes Metab Syndr; 2023 Nov; 17(11):102882. PubMed ID: 37898064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH; Shlipak MG; Chertow GM; Whooley MA
    Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
    Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
    Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis.
    Einwoegerer CF; Domingueti CP
    Arq Bras Cardiol; 2018 Dec; 111(6):796-807. PubMed ID: 30281693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction.
    Corona G; Rastrelli G; Silverii A; Monami M; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2013 Apr; 10(4):1114-23. PubMed ID: 23347470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study.
    Deedwania P; Patel K; Fonarow GC; Desai RV; Zhang Y; Feller MA; Ovalle F; Love TE; Aban IB; Mujib M; Ahmed MI; Anker SD; Ahmed A
    Int J Cardiol; 2013 Oct; 168(4):3616-22. PubMed ID: 23731526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Risk of Hypertension in Normoglycemia and Prediabetes, and Their Relation to the Change of Glycemic State.
    Jung JY; Oh CM; Choi JM; Ryoo JH; Park SK
    Am J Hypertens; 2018 Aug; 31(9):1042-1048. PubMed ID: 29931224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome increases cardiovascular risk in a population with prediabetes: A prospective study in a cohort of Chinese adults.
    Chen Z; Wu S; Huang J; Yuan J; Chen H; Chen Y
    J Diabetes Investig; 2019 May; 10(3):673-679. PubMed ID: 30312020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.
    Lind M; Jansson JH; Nilsson TK; Järvholm LS; Johansson L
    Thromb Res; 2013 Aug; 132(2):e77-82. PubMed ID: 23834818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Persistent, Incident, and Remittent Proteinuria With Stroke Risk in Patients With Diabetes Mellitus or Prediabetes Mellitus.
    Wang A; Jiang R; Su Z; Zhang J; Zhao X; Wu S; Guo X
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a multi-marker risk score for predicting cause-specific mortality at three years in older patients with heart failure and reduced ejection fraction.
    Bjurman C; Holmström A; Petzold M; Hammarsten O; Fu ML
    Cardiol J; 2015; 22(1):31-6. PubMed ID: 24526512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediabetes and incident heart failure in hypertensive patients: Results from the Swedish Primary Care Cardiovascular Database.
    Johansson JSM; Boström KB; Hjerpe P; Mourtzinis G; Kahan T; Ljungman C
    Nutr Metab Cardiovasc Dis; 2022 Dec; 32(12):2803-2810. PubMed ID: 36328837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.